Search results
ESSENCE Fest 2024: Medical Experts Call For Inclusive And Compassionate Health Care For Black...
Essence· 18 hours ago...Gynecology at Health Alliance Hospital; and Kelly Copes-Anderson, Global Head of Diversity,...
Company News for July 9, 2024
Zacks via Yahoo Finance Canada· 2 days agoMorphic Holding, Inc. (MORF) shares surged 75.1% on news that Eli Lilly and Company (LLY) will acquire the biopharmaceutical ...
Pfizer targets obesity with new once-daily Danuglipron drug
ABC7 New York· 2 hours agoPfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation of danuglipron, a move that it said was a significant milestone in the obesity ...
Seae Ventures acquires Unseen Capital after founder death
TechCrunch· 2 days agoSeae Ventures is acquiring Unseen Capital after the death of founder Kayode Owens in 2021. The...
Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal
Bloomberg via Yahoo Finance Canada· 3 days ago(Bloomberg) -- Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices
AOL· 17 hours agoSenator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be convinced to cut the U.S. prices of its popular Ozempic and Wegovy used for weight loss by ...
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials
The Independent via Yahoo Canada News· 3 days agoTirzepatide, which is sold under the brand names Mounjaro and Zepbound – which treat diabetes and...
FDA approves new Alzheimer’s treatment for early-stage patients
Daily Sabah· 1 day agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla for mild or early cases of dementia caused by Alzheimer’s. It’s only ...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 6 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
FTC to sue drug managers amid insulin price hikes
Investing.com via Yahoo Finance Canada· 22 hours agoInvesting.com - The Federal Trade Commission (FTC) is gearing up to sue the top three pharmacy-benefit managers (PBMs) over their strategies for negotiating drug prices, including insulin. This ...
